Polivy 140 mg
Polivy 140 mg is a medicine authorised by Swissmedic under authorisation number 67165. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 15 June 2021 and the authorisation is valid without a time limit. ATC code L01FX14 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67165 |
|---|---|
| Name | Polivy 140 mg |
| Full name | Polivy 140 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Roche Pharma (Schweiz) AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FX14 |
| First authorisation | 15 June 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Polivy 140 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 15 June 2021 |
| 2 | Polivy 30 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 15 June 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 1 | Durchstechflasche(n) | L01FX14 | 07.16.1. | A |
| 1 | 1 | Durchstechflasche(n) | L01FX14 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Polivy 140 mg authorised in Switzerland?
Yes. Polivy 140 mg is authorised by Swissmedic under authorisation number 67165, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Polivy 140 mg have?
Polivy 140 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Polivy 140 mg?
The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.